Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays

In November 2022, 68% of the population received at least one dose of COVID-19 vaccines. Owing to the ongoing mutations, especially for the variants of concern (VOCs), it is important to monitor the humoral immune responses after different vaccination strategies. In this study, we developed a SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ho-Chang, Kuo, Kuang-Che, Du, Pin-Xian, Keskin, Batuhan Birol, Su, Wen-Yu, Ho, Tzong-Shiann, Tsai, Pei-Shan, Pau, Chi Ho, Shih, Hsi-Chang, Huang, Ying-Hsien, Weng, Ken-Pen, Syu, Guan-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922205/
https://www.ncbi.nlm.nih.gov/pubmed/36787877
http://dx.doi.org/10.1016/j.mcpro.2023.100507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922205/
https://www.ncbi.nlm.nih.gov/pubmed/36787877
http://dx.doi.org/10.1016/j.mcpro.2023.100507

Ejemplares similares